How many stocks are there of Stratec Se?
The current number of stocks of Stratec Se is 12.16 M undefined.
Stratec Se Stocks 2025
Stratec Se Stocks
12.16 M
Ticker
SBS.DE
ISIN
DE000STRA555
WKN
STRA55
In 2025, Stratec Se had 12.16 M outstanding stocks, a 0% change from the 12.16 M stocks in the previous year.
The Stratec Se Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2029e | 12.16 |
| 2028e | 12.16 |
| 2027e | 12.16 |
| 2026e | 12.16 |
| 2025e | 12.16 |
| 2024e | 12.16 |
| 2023 | 12.16 |
| 2022 | 12.17 |
| 2021 | 12.18 |
| 2020 | 12.15 |
| 2019 | 12.06 |
| 2018 | 12.03 |
| 2017 | 11.98 |
| 2016 | 11.94 |
| 2015 | 11.92 |
| 2014 | 11.83 |
| 2013 | 11.8 |
| 2012 | 11.7 |
| 2011 | 11.7 |
| 2010 | 11.7 |
| 2009 | 11.4 |
| 2008 | 11.4 |
| 2007 | 11.4 |
| 2006 | 11.4 |
| 2005 | 10.5 |
| 2004 | 10 |
Stratec Se shares outstanding DE000STRA555 · STRA55
The number of shares was Stratec Se in 2024 — This indicates how many shares 12.159 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Stratec Se earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Stratec Se's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Stratec Se’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Stratec Se's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2004 | 10 M Aktien |
| 2005 | 10.5 M Aktien |
| 2006 | 11.4 M Aktien |
| 2007 | 11.4 M Aktien |
| 2008 | 11.4 M Aktien |
| 2009 | 11.4 M Aktien |
| 2010 | 11.7 M Aktien |
| 2011 | 11.7 M Aktien |
| 2012 | 11.7 M Aktien |
| 2013 | 11.8 M Aktien |
| 2014 | 11.83 M Aktien |
| 2015 | 11.92 M Aktien |
| 2016 | 11.94 M Aktien |
| 2017 | 11.98 M Aktien |
| 2018 | 12.03 M Aktien |
| 2019 | 12.06 M Aktien |
| 2020 | 12.15 M Aktien |
| 2021 | 12.18 M Aktien |
| 2022 | 12.17 M Aktien |
| 2023 | 12.16 M Aktien |
| 2024e | 12.16 M Aktien |
| 2025e | 12.16 M Aktien |
| 2026e | 12.16 M Aktien |
| 2027e | 12.16 M Aktien |
| 2028e | 12.16 M Aktien |
| 2029e | 12.16 M Aktien |
Stratec Se Aktienanalyse
What does Stratec Se do?
The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Stratec Se's Shares Outstanding
Stratec Se's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Stratec Se’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Stratec Se’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Stratec Se’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Stratec Se stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Stratec Se are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Stratec Se evolved in recent years?
The number of shares of Stratec Se has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Stratec Se as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Stratec Se?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Stratec Se pay?
Over the past 12 months, Stratec Se paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about 3.02 %. For the coming 12 months, Stratec Se is expected to pay a dividend of 1.05 EUR.
What is the dividend yield of Stratec Se?
The current dividend yield of Stratec Se is 3.02 %.
When does Stratec Se pay dividends?
Stratec Se pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Stratec Se?
Stratec Se paid dividends every year for the past 0 years.
What is the dividend of Stratec Se?
For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 3.27 %.
In which sector is Stratec Se located?
Stratec Se is assigned to the 'Health' sector.
Wann musste ich die Aktien von Stratec Se kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Stratec Se from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.
When did Stratec Se pay the last dividend?
The last dividend was paid out on 5/22/2024.
What was the dividend of Stratec Se in the year 2024?
In the year 2024, Stratec Se distributed 0.97 EUR as dividends.
In which currency does Stratec Se pay out the dividend?
The dividends of Stratec Se are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Stratec Se stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Stratec Se
Our stock analysis for Stratec Se Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Se Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
